Skip to main content

Table 5 Total fatty acid composition of plasma lipids

From: Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice

Fatty acids

High fat

FO

KO

K-W

 

μg FA/ml plasma

μg FA/ml plasma

μg FA/ml plasma

p

SFA

1255 (889–1928)

715 (570–731)a**

735 (611–925)

0.001

C10:0

0.9 (0.4–3.2)

1.0 (0.7–1.4)

1.8 (1.2–2.1)

0.126

C12:0

1.5 (0.6–2.9)

0.4 (0.3–0.6)a**

0.7 (0.5–1.0)

0.001

C14:0

15.3 (7.4–24.3)

5.8 (4.1–6.7)a**

11.4 (9.2–20.5)

0.003

C16:0

781 (524–1170)

422 (359–436)a**

482 (379–596)

0.002

C18:0

402 (311–637)

242 (181–271)a**

228 (187–274)b**

0.001

C20:0

11.0 (7.6–19.5)

4.6 (3.7–5.4)a***

6.4 (5.1–8.1)

0.003

C22:0

16.2 (10.6–26.6)

9.7 (7.7–10.3)

13.1 (10.7–17.3)

0.199

C24:0

5.0 (2.8–8.4)

3.9 (3.0–4.2)a**

3.8 (3.8–4.8)

0.001

MUFA

679 (493–1115)

277 (217–292)a***

351 (331–527)

0.001

C16:1n–9

11.7 (7.5–17.4)

4.4 (4.0–4.9)a**

5.7 (4.7–8.2)

0.001

C16:1n–7

45.2 (23.9–51.8)

18.9 (14.6–24.5)a**, c*

35.0 (24.7–53.0)

0.007

C18:1n–9

543 (397–919)

218 (170–232)a***

254 (241–390)

0.000

C18:1n–7

42.5 (33.0–70.5)

20.1 (14.3–22.7)a**

36.9 (30.6–45.1)

0.004

C20:1n–9

12.9 (8.7–24.8)

3.7 (2.9–4.8)a***

5.9 (4.6–7.6)

0.001

C20:1n–7

2.6 (1.7–4.2)

1.1 (0.8–1.4)a**

2.0 (1.8–2.5)

0.002

C22:1n–9

2.0 (1.3–4.1)

0.5 (0.4–0.6)a*, c**

3.0 (2.3–3.5)

0.004

C22:1n–7

1.4 (0.9–1.7)

0.6 (0.5–0.7)c***

2.1 (1.8–2.6)

0.000

C24:1n–9

9.6 (6.5–14.3)

7.2 (6.3–7.8)a*

7.5 (6.0–10.2)

0.040

ω-6 PUFA

1490 (1080–2176)

468 (419–527)a***

744 (513–815)

0.001

C18:2n–6

969 (677–1461)

283 (214–293)a***

562 (351–615)

0.000

C18:3n–6

14.1 (8.2–22.8)

2.6 (2.3–3.0)a***

4.8 (3.0–5.2)

0.001

C20:3n–6

48.4 (30.2–69.2)

12.8 (12.0–15.5)a**

15.0 (10.8–21.0)b*

0.001

C20:4n–6

455 (338–588)

189 (167–219)

136 (123–166)b***

0.000

C22:4n–6

5.8 (4.2–10.3)

1.1 (0.8–1.1)a**

1.2 (1.0–1.4)b*

0.001

C22:5n–6

7.7 (4.3–12.0)

3.1 (2.5–3.8)

1.3 (1.1–1.6)b***

0.000

ω 3 PUFA

272 (187–415)

773 (639–898)a**

696 (588–877)b**

0.001

C18:3n–3

18.3 (10.4–29.3)

3.8 (2.3–6.4)a**

11.3 (5.6–16.9)

0.002

C20:5n–3

21.4 (13.1–28.3)

420 (351–512)a**

400 (316–486)b*

0.001

C22:6n–3

212 (147–328)

261 (248–331)a*

268 (231–334)b*

0.013

C22:5n–3

14.1 (9.6–19.9)

31.2 (24.1–35.0)a**

26.0 (19.1–33.4)b*

0.002

ω- 3/ω- 6 PUFA

0.2 (0.2–0.2)

1.6 (1.5–1.7)a***

1.1 (0.8–1.4)

0.000

Total FA

3712 (2679–5648)

2282 (1849–2427)a**

2406 (2175–3079)

0.002

  1. Quantitative fatty acid composition of selected fatty acids in plasma. SFA; saturated fatty acids, MUFA; monounsaturated fatty acids, PUFA; polyunsaturated fatty acids. Data are shown as median and range. High fat (n = 9), FO (n = 5), KO (=6). a = HF vs. FO, p <0.05, b = HF vs. KO, p <0.05, c = FO vs. KO, *= p <0.05, **= p <0.01 and ***= p <0.001. K-W, p indicates the p-value with the Kruskal-Wallace test. FO; fish oil, KO; Krill oil.